| |
|
|
|
Five Prime Thera  
|
|
23.43 1.2 (0.05%) |
03-01 16:00 |
|
Open: |
22.57 |
Pre close: |
22.23 |
Target:
|
30.66
|
|
High: |
24.8 |
Low: |
22.57 |
Resistance:
|
26.25
30.66
|
|
Volume: |
813,764 |
Market Cap: |
891M |
Support:
|
18.69
 14.02
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
23.58
 |
MACD |
MACD(12,26):
|
1.71 |
|
MA(20): |
20.99 |
Signal(12,26,9): |
1.55 |
|
MA(100): |
15.09 |
Stochastic Oscillator |
%K(14,3):
|
56.98 |
|
MA(250): |
8.65 |
%D(3): |
69.57 |
|
Average Volume(K) |
3-Month: |
93255
|
52-Week |
High:
|
26.25 |
|
10-Days: |
108621 |
Low: |
1.75 |
|
RSI |
RSI(14):
|
61.70 |
Change(%): |
477.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.680 |
Return on Equity (ttm) |
-69.3 |
Shares Out. (M) |
38.04 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-26.2 |
Shares Float (M) |
36.10 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.19 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-31.4 |
% Held by Institutions |
47.10 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
-2.444 |
Shares Short (K) |
2250 |
|
Book Value (p.s.) |
2.670 |
EBITDA (p.s.) |
-2.196 |
P/E |
-8.74 |
|
Sales Per Share |
0.450 |
Qtrly Earnings Growth |
0.00 |
P/BV |
8.78 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-81.01 |
P/S |
52.12 |
|
Operating Margin |
-513.07 |
Levered Free Cash Flow
(M) |
-44.87 |
P/CF |
-11.00 |
|
|
|
|
|
|
